PRO-ACT

Other names: Pooled Resource Open-Access ALS Clinical Trials Database

The PRO-ACT platform houses the largest ALS clinical trials dataset ever created. It is a powerful tool for biomedical researchers, statisticians, clinicians, or anyone else interested in "Big Data." PRO-ACT merges data from existing public and private clinical trials, generating an invaluable resource for the design of future ALS clinical trials. The database will also contribute to the identification of unique observations, novel correlations, and patterns of ALS disease progression, as well as a variety of still unconsidered analyses. More than 600,000 people around them world are battling ALS. The disease strikes indiscriminately, and typically patients will die within 2-5 years following diagnosis. Currently, there are no effective treatments or a cure for ALS. Users of PRO-ACT are helping to accelerate the discovery, development, and delivery of ALS treatments, which will provide hope to patients and their families.

Webpage:
https://nctu.partners.org/ProACT/

Licence:
Name: other
URL: https://nctu.partners.org/ProACT/Document/DisplayLatest/1

Tags:

amyotrophic lateral sclerosis lou gehrig's disease clinical trial neurodegenerative illness psychometric assessment

More to explore:

1/20

Previous Next   



Need help integrating and/or managing biomedical data?